|
Volumn 13, Issue 5, 2012, Pages 525-528
|
Conference Scene: Golden Helix Pharmacogenomics Days: Educational activities on pharmacogenomics and personalized medicine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
CARBAMAZEPINE;
DASATINIB;
HEMOGLOBIN;
HLA A ANTIGEN;
IMATINIB;
LITHIUM;
NILOTINIB;
VASCULOTROPIN;
ACCN1 GENE;
ALLELE;
BIOINFORMATICS;
BIPOLAR DISORDER;
CARDIOVASCULAR DISEASE;
CHRONIC MYELOID LEUKEMIA;
CONFERENCE PAPER;
DNA MICROARRAY;
DRUG EXCRETION;
DRUG METABOLISM;
DRUG TRANSPORT;
EUROPE;
EVIDENCE BASED MEDICINE;
GENE;
GENE EXPRESSION REGULATION;
GENE SEQUENCE;
GENETIC VARIABILITY;
HEMOGLOBINOPATHY;
HUMAN;
KLF1 GENE;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL EDUCATION;
MEDICAL PRACTICE;
MEDICAL RESEARCH;
MENTAL DISEASE;
NEXT GENERATION SEQUENCING;
PHARMACODYNAMICS;
PHARMACOGENOMICS;
QUALITY OF LIFE;
TREATMENT RESPONSE;
UNITED STATES;
VIDEOCONFERENCING;
ARTICLE;
EDUCATION;
ITALY;
METHODOLOGY;
ORGANIZATION;
PERSONALIZED MEDICINE;
PHARMACOGENETICS;
CONGRESSES AS TOPIC;
INDIVIDUALIZED MEDICINE;
ITALY;
PHARMACOGENETICS;
|
EID: 84859229190
PISSN: 14622416
EISSN: 17448042
Source Type: Journal
DOI: 10.2217/pgs.12.22 Document Type: Conference Paper |
Times cited : (10)
|
References (8)
|